scienceneutral
New Tool Helps Scientists Explore Rare Brain Receptors
Thursday, February 26, 2026
To see if the drug works in real brain tissue, researchers applied it to mouse brain slices. They found that UCM‑A86 increased signals from GluN3 receptors in certain cells called somatostatin interneurons, which are found in the part of the brain that processes touch. It did not change signals from other receptors in the same tissue.
Further experiments suggest that UCM‑A86 helps the receptor stay open longer when glycine is present, but it does not change how much charge passes through the channel. This points to a specific way the drug enhances receptor activity.
Because tools that can selectively target GluN3 receptors are rare, UCM‑A86 gives researchers a new way to study how these receptors influence brain development and function. It may also help scientists explore whether GluN3 receptors play a role in brain disorders.
Actions
flag content